ChromaDex Launches Tru Niagen® Immune, Further Expanding Innovative Product Portfolio

LOS ANGELES–(BUSINESS WIRE)—- $CDXC #NAD–ChromaDex Corp. (NASDAQ:CDXC) today announced the company’s latest product innovation with the U.S. launch of Tru Niagen® Immune, a first-of-its-kind combination of ChromaDex’s proprietary NAD-boosting ingredient Niagen® (patented nicotinamide riboside or NR), high-quality and proven immune-boosting nutrients (vitamins C, D, and zinc) for the optimal maintenance…